John E. Connett

Active 1981–2024

87
Papers
19,138
Citations
73
h-index
86
i10-index

Citations

Citations per year for John E. Connett1982: 1 citations1983: 1 citations1984: 2 citations1985: 1 citations1988: 1 citations1990: 1 citations1991: 10 citations1992: 5 citations1993: 10 citations1994: 22 citations1995: 17 citations1996: 27 citations1997: 39 citations1998: 39 citations1999: 38 citations2000: 75 citations2001: 58 citations2002: 85 citations2003: 123 citations2004: 116 citations2005: 144 citations2006: 184 citations2007: 152 citations2008: 129 citations2009: 166 citations2010: 156 citations2011: 156 citations2012: 174 citations2013: 153 citations2014: 170 citations2015: 159 citations2016: 157 citations2017: 145 citations2018: 141 citations2019: 380 citations2020: 374 citations2021: 373 citations2022: 324 citations2023: 267 citations2024: 350 citations2025: 140 citations2026: 5 citations1986–1987: no citations, so these years are not shown1989: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,036 citing papers, 28.4% of this breakdownUnited Kingdom: 785 citing papers, 10.9% of this breakdownCanada: 439 citing papers, 6.1% of this breakdownGermany: 303 citing papers, 4.2% of this breakdownAustralia: 296 citing papers, 4.1% of this breakdownChina: 292 citing papers, 4.1% of this breakdownNetherlands: 290 citing papers, 4% of this breakdownItaly: 275 citing papers, 3.8% of this breakdownSpain: 216 citing papers, 3% of this breakdownFrance: 190 citing papers, 2.7% of this breakdownDenmark: 149 citing papers, 2.1% of this breakdownSweden: 149 citing papers, 2.1% of this breakdown
0%28.4%Other 24.5%

Fields

  • Medicine80.8%
  • Biochemistry, Genetics and Molecular Biology7%
  • Engineering4.4%
  • Immunology and Microbiology1.2%
  • Psychology1.2%
  • Health Professions1.2%
  • Other4.2%

Topics

  • Chronic Obstructive Pulmonary Disease (COPD) Research12%
  • Asthma and respiratory diseases5.9%
  • Respiratory Support and Mechanisms4.5%
  • Smoking Behavior and Cessation3.4%
  • Bariatric Surgery and Outcomes2.7%
  • Respiratory and Cough-Related Research2.4%
  • Other69.1%

Coauthors

All papers

Open in search
  1. Advanced reperfusion strategies for patients with out-of-hospital cardiac arrest and refractory ventricular fibrillation (ARREST): a phase 2, single centre, open-label, randomised controlled trial

    Authors: , , , , , , , , , , , , , , , , , - The Lancet 2020 cited by 1,046

  2. Fibrotic extracellular matrix activates a profibrotic positive feedback loop

    Authors: , , , , , , , , , - Journal of Clinical Investigation 2014 cited by 546

  3. Azithromycin for Prevention of Exacerbations of COPD

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2011 cited by 1,207

  4. The Effects of a Smoking Cessation Intervention on 14.5-Year Mortality

    Authors: , , , , , - Annals of Internal Medicine 2005 cited by 1,241

  5. Lifestyle Intervention and Medical Management With vs Without Roux-en-Y Gastric Bypass and Control of Hemoglobin A 1c , LDL Cholesterol, and Systolic Blood Pressure at 5 Years in the Diabetes Surgery Study

    Authors: , , , , , , , , , , , , , , , , - JAMA 2018 cited by 288

  6. Coronary Artery Disease in Patients With Out-of-Hospital Refractory Ventricular Fibrillation Cardiac Arrest

    Authors: , , , , , , , , , , , - Journal of the American College of Cardiology 2017 cited by 320

  7. Metoprolol for the Prevention of Acute Exacerbations of COPD

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jeremy A. Weingarten, J. Michael Wells, Elizabeth Westfall, Stephen C. Lazarus, John E. Connett - New England Journal of Medicine 2019 cited by 178

  8. Roux-en-Y Gastric Bypass vs Intensive Medical Management for the Control of Type 2 Diabetes, Hypertension, and Hyperlipidemia

    Authors: , , , , , , , , , , , , , , , , , , - JAMA 2013 cited by 735

  9. Simvastatin for the Prevention of Exacerbations in Moderate-to-Severe COPD

    Authors: , , , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2014 cited by 347

  10. Prolonged partial liquid ventilation using conventional and high-frequency ventilatory techniques

    Authors: , , , , , , - Critical Care Medicine 1997 cited by 236

  11. Roux-en-Y gastric bypass for diabetes (the Diabetes Surgery Study): 2-year outcomes of a 5-year, randomised, controlled trial

    Authors: , , , , , , , , , , , , , , , , , , , , , - The Lancet Diabetes & Endocrinology 2015 cited by 200

  12. Health Coaching and Chronic Obstructive Pulmonary Disease Rehospitalization: A Randomized Study

    Authors: , , , , , , , , - American Journal of Respiratory and Critical Care Medicine 2016 cited by 175

  13. Smoking Cessation and Lung Function in Mild-to-Moderate Chronic Obstructive Pulmonary Disease: The Lung Health Study

    Authors: , , , , , - American Journal of Respiratory and Critical Care Medicine 2000 cited by 735

  14. Smoking and Lung Function of Lung Health Study Participants after 11 Years

    Authors: , , - American Journal of Respiratory and Critical Care Medicine 2002 cited by 702

  15. Development of Conceptual Models to Guide Public Health Research, Practice, and Policy: Synthesizing Traditional and Contemporary Paradigms

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Ariana L. Smith, Jean F. Wyman, Siobhan Sutcliffe, Colleen McNicholas, Aimee S. James, Jerry L. Lowder, Leslie Rickey, Deepa R. Camenga, Shayna D. Cunningham, Toby C. Chai, Jessica B. Lewis, Bernard L. Harlow, Kyle Rudser, John E. Connett, Haitao Chu, Cynthia S. Fok, Todd Rockwood, Melissa L. Constantine - Health Promotion Practice 2020 cited by 72

  16. Randomized Trial of Mindfulness-Based Stress Reduction in Cardiac Patients Eligible for Cardiac Rehabilitation

    Authors: , , , , , , , , , , , - Scientific Reports 2019 cited by 59

  17. Predictors of Chronic Obstructive Pulmonary Disease Exacerbation Reduction in Response to Daily Azithromycin Therapy

    Authors: , , , , , , , , , , , , - American Journal of Respiratory and Critical Care Medicine 2014 cited by 192

  18. CKD Progression Risk and Subsequent Cause of Death: A Population-Based Cohort Study

    Authors: , , , , - Kidney Medicine 2023 cited by 33

  19. Rationale and methods of the Advanced R2Eperfusion STrategies for Refractory Cardiac Arrest (ARREST) trial

    Authors: , , , , , , , - American Heart Journal 2020 cited by 32

  20. Effects of smoking intervention and the use of an inhaled anticholinergic bronchodilator on the rate of decline of FEV1. The Lung Health Study.

    Authors: , , , , , , , , , - 1994 cited by 665

  21. Lower Respiratory Illnesses Promote FEV1 Decline in Current Smokers But Not Ex-Smokers with Mild Chronic Obstructive Pulmonary Disease

    Authors: , , - American Journal of Respiratory and Critical Care Medicine 2001 cited by 591

  22. Effects of randomized assignment to a smoking cessation intervention and changes in smoking habits on respiratory symptoms in smokers with early chronic obstructive pulmonary disease: the lung health study

    Authors: , , , - The American Journal of Medicine 1999 cited by 277

  23. Inflammation in Areas of Tubular Atrophy in Kidney Allograft Biopsies: A Potent Predictor of Allograft Failure

    Authors: , , , , , , , , , , , , - American Journal of Transplantation 2010 cited by 229

  24. Durability of Addition of Roux-en-Y Gastric Bypass to Lifestyle Intervention and Medical Management in Achieving Primary Treatment Goals for Uncontrolled Type 2 Diabetes in Mild to Moderate Obesity: A Randomized Control Trial

    Authors: , , , , , , , , , , , , , , , , , , - Diabetes Care 2016 cited by 98